R1 RCM Inc
NASDAQ:RCM
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
9.11
14.49
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one RCM stock under the Base Case scenario is 15.266 USD. Compared to the current market price of 14.305 USD, R1 RCM Inc is Undervalued by 6%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
R1 RCM Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for RCM cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
R1 RCM Inc
Balance Sheet Decomposition
R1 RCM Inc
Current Assets | 768.9m |
Cash & Short-Term Investments | 167.3m |
Receivables | 456.2m |
Other Current Assets | 145.4m |
Non-Current Assets | 5B |
PP&E | 281.1m |
Intangibles | 4.6B |
Other Non-Current Assets | 144.9m |
Current Liabilities | 429.6m |
Accounts Payable | 34.4m |
Accrued Liabilities | 262.1m |
Other Current Liabilities | 133.1m |
Non-Current Liabilities | 2.5B |
Long-Term Debt | 2.1B |
Other Non-Current Liabilities | 371.9m |
Earnings Waterfall
R1 RCM Inc
Revenue
|
2.5B
USD
|
Cost of Revenue
|
-2B
USD
|
Gross Profit
|
472.7m
USD
|
Operating Expenses
|
-274m
USD
|
Operating Income
|
198.7m
USD
|
Other Expenses
|
-259.9m
USD
|
Net Income
|
-61.2m
USD
|
Free Cash Flow Analysis
R1 RCM Inc
USD | |
Free Cash Flow | USD |
In Q2 2024, the company reported substantial growth with revenues up by 12% to $627.9 million and adjusted EBITDA reaching $156.1 million. This growth was attributed mainly to the inclusion of Acclara and expansion in the Modular business, despite disruptions from cyberattacks. The company also launched significant operational and technological initiatives, including AI and automation improvements. The Ascension cyberattack is expected to impact revenues by $75-$95 million and will incur additional costs of $10-$15 million in the latter half of the year. Despite this, the long-term outlook remains positive with recovery expected in 2025.
What is Earnings Call?
RCM Profitability Score
Profitability Due Diligence
R1 RCM Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
Score
R1 RCM Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
RCM Solvency Score
Solvency Due Diligence
R1 RCM Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.
Score
R1 RCM Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RCM Price Targets Summary
R1 RCM Inc
According to Wall Street analysts, the average 1-year price target for RCM is 14.809 USD with a low forecast of 14.14 USD and a high forecast of 17.85 USD.
Dividends
Current shareholder yield for RCM is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
R1 RCM, Inc. engages in the provision of revenue cycle management to healthcare providers. The company is headquartered in Chicago, Illinois and currently employs 10,200 full-time employees. The company went IPO on 2010-05-20. The firm's services help healthcare providers generate sustainable improvements in their operating margins and cash flows while also improving patient, physician, and staff satisfaction for its customers. Its primary service offering consists of end-to-end RCM services for health systems, hospitals, and physician groups. The company also offers modular services, allowing customers to engage for only specific components of its end-to-end RCM service offering, such as physician advisory services (PAS), practice management (PM), revenue integrity solutions (RIS), patient experience (PX), coding management, and business office services. Its PAS offering assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes.
Contact
IPO
Employees
Officers
The intrinsic value of one RCM stock under the Base Case scenario is 15.266 USD.
Compared to the current market price of 14.305 USD, R1 RCM Inc is Undervalued by 6%.